UK markets closed

ImmuPharma plc (IMM.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
2.2000+0.0550 (+2.56%)
At close: 03:21PM BST
Show:
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
69.959
0
118.35
126.667
77.925
Operating expenses
Research development
1,808
2,023
3,650
2,373
2,665
Selling general and administrative
703.248
846.571
1,011
1,765
1,831
Total operating expenses
2,728
3,029
5,278
5,716
6,360
Operating income or loss
-2,658
-3,029
-5,160
-5,589
-6,282
Interest expense
-173.698
2.036
124.063
230.828
4.045
Income before tax
-3,764
-4,456
-8,941
-7,246
-6,744
Income tax expense
-772.569
-648.902
-766.814
-386.248
-620.774
Income from continuing operations
-2,991
-3,807
-8,174
-6,860
-6,124
Net income
-2,991
-3,807
-8,174
-6,860
-6,124
Net income available to common shareholders
-2,991
-3,807
-8,174
-6,860
-6,124
Basic EPS
-0.01
-0.01
-0.03
-0.03
-0.04
Diluted EPS
-0.01
-0.01
-0.03
-0.03
-0.04
Basic average shares
327,122
302,913
251,164
200,176
153,452
Diluted average shares
327,122
302,913
251,164
200,176
153,452